IL17A and myeloid sarcoma: IL-6 and transforming growth factor-beta (TGF-β) stimulate increased secretion of IL-17 and IL-21 and thus the differentiation of Th17 T helper cells via the activation of STAT3, which is characteristic of various autoimmune diseases, including MS.